Earnings call transcript: Ecopetrol exceeds Q1 2026 earnings forecasts

Ecopetrol delivered a strong Q1 2026 beat, with EPS of 2,190.69 COP versus 1,457.82 COP expected and revenue of 28.6 trillion COP versus 23.5 trillion COP, while EBITDA margin expanded to 47%. Refining was a key driver, with throughput up 5% year over year to 417,000 bpd and refining gross margin rising 60% to $17.3/bbl, though the ADR still fell 2.14% premarket. Management kept full-year production guidance at 730,000-740,000 boe/d and reiterated growth plans tied to Brava Energia, gas import infrastructure, and renewable expansion.

Analysis

The market’s knee-jerk selloff looks less like an earnings miss and more like a credibility discount on the durability of the beat. The core issue is that a large share of the quarter’s upside came from refining and FX-adjacent moving parts that can mean-revert quickly, while the market is still trying to handicap whether the company can preserve cash generation after layering in logistics inflation, higher tax drag, and potential execution risk from a more aggressive M&A agenda. In other words, this was a “good quarter, worse forward debate” print.

Second-order, the quarter strengthens downstream peers and refiners globally because it validates that crack-spread capture is still available even in a volatile crude tape. But for upstream-heavy LATAM exposure, the real implication is that capital may keep migrating toward integrated names with refining or infrastructure optionality, which leaves pure producers more exposed to commodity and policy volatility. The gas import/regasification push is also strategically important: it is effectively a hedge against domestic gas decline, but it creates a new class of regulated/merchant infrastructure risk that could suppress near-term ROE if utilization ramps slower than expected.

The Brava transaction is the biggest potential swing factor: if sized correctly, it can be accretive via reserve replacement and offshore capability transfer, but it also shifts the story from self-help to balance-sheet management. The market is likely underpricing the refinance risk because bridge funding is manageable only if Brent stays supportive and FX doesn’t move against them; a weaker oil tape or stronger peso would quickly compress equity value through both EBITDA and leverage optics. The contrarian read is that the current pullback may be overdone if investors are extrapolating headline tax and acquisition risk without fully pricing the embedded optionality from higher refining margins and gas replacement, but that optionality is best monetized over months, not days.

Key Decisions for Investors

• Long EC on weakness for a 1-3 month horizon; use the post-earnings dip as entry, targeting a re-rate if management proves refining margins are structurally higher and the Brava process stays disciplined. Risk/reward: ~10-15% upside vs mid-single-digit downside if crude and FX stabilize.
• Buy EC Jan/Apr call spreads rather than outright equity to express upside on a commodity-supported FY26 while capping downside from deal execution or tax overhang. Best if Brent remains in the upper end of management’s range for the next 2-3 quarters.
• Pair trade: long EC / short a pure upstream LATAM producer basket (e.g., PBR or ISA-adjacent commodity-sensitive peers, depending on fund universe) to isolate downstream and infrastructure optionality from outright oil beta. Thesis works if crack spreads stay firm and the market continues rewarding integrated cash flow.
• If we want a cleaner macro hedge, short COP/USD FX-sensitive domestically oriented names against EC; the report highlights that FX is now a bigger earnings variable than many investors are modeling, and EC has more natural hedges than local industrials. Timeframe: 1-2 months.
• Avoid chasing the Brava headline until financing terms are clearer; if the market starts to price an equity-funded deal or delayed refinancing, fade rallies and wait for confirmation of leverage trajectory before adding risk.